Treace Medical Concepts I... (TMCI)
6.45
-0.07 (-1.07%)
At close: Apr 17, 2025, 3:59 PM
6.55
1.60%
After-hours: Apr 17, 2025, 07:56 PM EDT
-1.07% (1D)
| Bid | 6.42 |
| Market Cap | 405.33M |
| Revenue (ttm) | 209.36M |
| Net Income (ttm) | -55.74M |
| EPS (ttm) | -0.9 |
| PE Ratio (ttm) | -7.16 |
| Forward PE | -9.21 |
| Analyst | Hold |
| Ask | 6.55 |
| Volume | 268,812 |
| Avg. Volume (20D) | 420,591 |
| Open | 6.51 |
| Previous Close | 6.52 |
| Day's Range | 6.42 - 6.59 |
| 52-Week Range | 3.92 - 11.51 |
| Beta | 0.78 |
About TMCI
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers pro...
Industry Medical - Devices
Sector Healthcare
IPO Date Apr 23, 2021
Employees 477
Stock Exchange NASDAQ
Ticker Symbol TMCI
Website https://www.treace.com
Analyst Forecast
According to 7 analyst ratings, the average rating for TMCI stock is "Hold." The 12-month stock price forecast is $8, which is an increase of 24.13% from the latest price.
Stock ForecastsNext Earnings Release
Treace Medical Concepts Inc. is scheduled to release its earnings on May 6, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+14.52%
Treace Medical Concepts shares are trading higher ...
Unlock content with
Pro Subscription
3 months ago
+8.14%
Treace Medical Concepts shares are trading higher after Lake Street initiated coverage on the stock with a Buy rating and announced a price target of $14.5.
